RASAL2 and ovarian carcinoma: To functionally validate the role of RASAL2 in ovarian cancers, we suppressed the expression of RASAL2 in ovarian cancer cell lines (SK-OV-3, OVCAR3 and A2780) using short-hairpin RNAs (shRNA), which targeted 2 different sequences in RASAL2.